FDA Approves Drug for Most Deadly Form of TB

  • 📰 WebMD
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The FDA has approved a new drug that could be a breakthrough in treating the deadliest form of tuberculosis -- the leading infectious killer in the world.

, increased liver enzymes, indigestion, rash, increased pancreatic enzymes, visual impairment, low blood sugar and diarrhea.TB is now the leading cause of infectious deaths worldwide, according to the. While only a fraction of the 10 million people who get TB get this deadly strain, very few of the 30,000 people in 100 countries who get XDR-TB survive, the newspaper said. Three-quarters die before there is even a diagnosis, experts believe.

"The bacterium that causes tuberculosis can develop resistance to the antibiotics used to treat it. Multidrug-resistant TB and extensively drug-resistant TB are public health threats due to limited treatment options. New treatments are important to meet patient national and global health needs," Abernethy said.WebMD News from HealthDayCopyright © 2013-2018 HealthDay. All rights reserved.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 709. in LAW

Law Law Latest News, Law Law Headlines